About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

RECRUITINGNA

CLEAR-AS: CT-FFR-Guided Revascularization in Patients With Severe Aortic Stenosis

CT-FFR-Guided Revascularization in Patients With Severe Aortic Stenosis: A Randomized Controlled Trial

NCT07469371•Yan'an Affiliated Hospital of Kunming Medical University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Severe Aortic Stenosis

Interventions

CCTA plus CT-FFR-informed preoperative decision strategy

CCTA-guided preoperative decision strategy

Locations

1

China

Locations (1)

Yan'an Hospital Affiliated to Kunming Medical University

Kunming, Yunnan, China

Key Dates

Start Date

April 1, 2026

Primary Completion Date

December 1, 2027

Completion Date

December 1, 2027

Last Updated

April 16, 2026

Related Studies

A Prospective, Multicenter, Single-arm Study to Evaluate a Transcatheter Aortic Valve System Safety and Efficacy for the Treatment of Patients With Severe Aortic Stenosis

NCT06136429

Severe Aortic Stenosis

Active Not RecruitingNA

Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).

NCT01586910

Severe Aortic Stenosis

Active Not RecruitingNA

Portico Next Generation Approval Study

NCT04011722

Symptomatic Severe Aortic Stenosis

Alwide Plus China Post-market Clinical Investigation

NCT07304427

Severe Aortic StenosisTranscatheter Aortic Valve Replacemen

Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement

NCT01531374

Severe Aortic Stenosis

Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement

NCT01240902

Severe Aortic Stenosis

View all related studies

Contacts

Xirui Duan

CONTACT

+86 13294957739 248190836@qq.com

Sponsors

Lead Sponsor

Yan'an Affiliated Hospital of Kunming Medical University

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 16, 2026Data synced to Clareo: April 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions